|
1
|
Gebhardt M, Mentlein R, Schaudig U, Pufe
T, Recker K, Nölle B, Al-Samir K, Geerling G and Paulsen FP:
Differential expression of vascular endothelial growth factor
implies the limbal origin of pterygia. Ophthalmology.
112:1023–1030. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kase S, Takahashi S, Sato I, Nakanishi K,
Yoshida K and Ohno S: Expression of p27(KIP1) and cyclin D1, and
cell proliferation in human pterygium. Br J Ophthalmol. 91:958–961.
2007. View Article : Google Scholar
|
|
3
|
Kase S, Osaki M, Sato I, Takahashi S,
Nakanishi K, Yoshida K, Ito H and Ohno S: Immunolocalisation of
E-cadherin and beta-catenin in human pterygium. Br J Ophthalmol.
91:1209–1212. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Detorakis ET, Zaravinos A and Spandidos
DA: Growth factor expression in ophthalmic pterygia and normal
conjunctiva. Int J Mol Med. 25:513–516. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kase S, Osaki M, Jin XH, Ohgami K, Yoshida
K, Saito W, Takahashi S, Nakanishi K, Ito H and Ohno S: Increased
expression of erythropoietin receptor in human pterygial tissues.
Int J Mol Med. 20:699–702. 2007.PubMed/NCBI
|
|
6
|
Ling S, Liang L, Lin H, Li W and Xu J:
Increasing lymphatic microvessel density in primary pterygia. Arch
Ophthalmol. 130:735–742. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fukuhara J, Kase S, Ohashi T, Ando R, Dong
Z, Noda K, Ohguchi T, Kanda A and Ishida S: Expression of vascular
endothelial growth factor C in human pterygium. Histochem Cell
Biol. 139:381–389. 2013. View Article : Google Scholar
|
|
8
|
Lin H, Luo L, Ling S, Chen W, Liu Z, Zhong
X, Wu C, Chen W and Liu Y: Lymphatic microvessel density as a
predictive marker for the recurrence time of pterygium: a
three-year follow-up study. Mol Vis. 19:166–173. 2013.PubMed/NCBI
|
|
9
|
Solomon A, Li DQ, Lee SB and Tseng SC:
Regulation of collagenase, stromelysin, and urokinase-type
plasminogen activator in primary pterygium body fibroblasts by
inflammatory cytokines. Invest Ophthalmol Vis Sci. 41:2154–2163.
2000.PubMed/NCBI
|
|
10
|
Cha HS, Bae EK, Koh JH, Chai JY, Jeon CH,
Ahn KS, Kim J and Koh EM: Tumor necrosis factor-alpha induces
vascular endothelial growth factor-C expression in rheumatoid
synoviocytes. J Rheumatol. 34:16–19. 2007.PubMed/NCBI
|
|
11
|
Kimura H, Mikami D, Kamiyama K, Sugimoto
H, Kasuno K, Takahashi N, Yoshida H and Iwano M: Telmisartan, a
possible PPAR-δ agonist, reduces TNF-α-stimulated VEGF-C production
by inhibiting the p38MAPK/HSP27 pathway in human proximal renal
tubular cells. Biochem Biophys Res Commun. 454:320–327. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Du Q, Jiang L, Wang X, Wang M, She F and
Chen Y: Tumor necrosis factor-α promotes the lymphangiogenesis of
gallbladder carcinoma through nuclear factor-κB-mediated
upregulation of vascular endothelial growth factor-C. Cancer Sci.
105:1261–1271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peppicelli S, Bianchini F and Calorini L:
Inflammatory cytokines induce vascular endothelial growth factor-C
expression in melanoma-associated macrophages and stimulate
melanoma lymph node metastasis. Oncol Lett. 8:1133–1138.
2014.PubMed/NCBI
|
|
14
|
Wen Y, Wang M, Yang J, Wang Y, Sun H, Zhao
J, Liu W, Zhou Z, Deng H, Castillo-Pedraza C, et al: A comparison
of fentanyl and flurbiprofen axetil on serum VEGF-C, TNF-α, and
IL-1β concentrations in women undergoing surgery for breast cancer.
Pain Pract. 15:530–537. 2015. View Article : Google Scholar
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)). Method Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
16
|
Brenner D, Blaser H and Mak TW: Regulation
of tumour necrosis factor signalling: live or let die. Nat Rev
Immunol. 15:362–374. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wajant H, Pfizenmaier K and Scheurich P:
Tumor necrosis factor signaling. Cell Death Differ. 10:45–65. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cook EB, Stahl JL, Graziano FM and Barney
NP: Regulation of the receptor for TNFalpha, TNFR1, in human
conjunctival epithelial cells. Invest Ophthalmol Vis Sci.
49:3992–3998. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Richards N, Batty T and Dilley A: CCL2 has
similar excitatory effects to TNF-α in a subgroup of inflamed
C-fiber axons. J Neurophysiol. 106:2838–2848. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kria L, Ohira A and Amemiya T:
Immunohistochemical localization of basic fibroblast growth factor,
platelet derived growth factor, transforming growth factor-beta and
tumor necrosis factor-alpha in the pterygium. Acta Histochem.
98:195–201. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sakimoto T, Yamada A and Sawa M: Release
of soluble tumor necrosis factor receptor 1 from corneal epithelium
by TNF-alpha-converting enzyme-dependent ectodomain shedding.
Invest Ophthalmol Vis Sci. 50:4618–4621. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kennedy M, Kim KH, Harten B, Brown J,
Planck S, Meshul C, Edelhauser H, Rosenbaum JT, Armstrong CA and
Ansel JC: Ultraviolet irradiation induces the production of
multiple cytokines by human corneal cells. Invest Ophthalmol Vis
Sci. 38:2483–2491. 1997.PubMed/NCBI
|
|
23
|
Yam JC and Kwok AK: Ultraviolet light and
ocular diseases. Int Ophthalmol. 34:383–400. 2014. View Article : Google Scholar
|
|
24
|
Díaz L, Villegas VM, Emanuelli A and
Izquierdo NJ: Efficacy and safety of intraoperative mitomycin C as
adjunct therapy for pterygium surgery. Cornea. 27:1119–1121. 2008.
View Article : Google Scholar : PubMed/NCBI
|
